The new rules will apply when the following four conditions are satisfied (ITEPA03/S451 (1)):
The new measure is directly targeted at the researcher’s
position when IP is transferred into a spin-out company from their
employer. It does not affect the position of the RI itself, except
that there will be no employer’s NICs to pay on the transfer
of the IP. Nor will it affect the RI’s position for Capital
Gains Tax (CGT) or Corporation Tax (CT). The spin-out company, and
researchers’ shares, remain within the scope of Part 7 of
ITEPA in all other respects.
In particular, where shares in a spin-out are acquired by a
researcher after other events (such as introduction of funding or
business development) have increased the value of the company,
there could still be a residual charge to Income Tax and NICs based
on shares acquired at less than market value, even though the
effect on value of the IP is being ignored
The relief covers only the transfer of IP from the RI. It
does not cover the transfer of any other item of value, such as
income from research contracts.